Article
Prevalence of the C282Y mutation of the hemochromatosis gene in liver transplant recipients and donors.
Hepatology (Baltimore, Md.) - 1 Sept 1999
Alanen K W, Chakrabarti S, Rawlins J J, Howson W, Jeffrey G, Adams P C
Abstract excerpt
Hemochromatosis heterozygotes may be predisposed to end-stage liver disease from other causes. The aims of this study were to determine the prevalence of the hemochromatosis mutation, C282Y, in end-stage liver disease and to determine if transplantation of C282Y heterozygous livers adversely affected survival. The C282Y status of patients who underwent hepatic transplantation and, whenever possible, their donors,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.